Figure 3From: Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis Flowchart showing the selection of the study population. ARB: angiotensin-receptor blocker, FDC: fixed-dose combination. Index date was defined as the first prescription date of FDC or ARB during the window time.Back to article page